These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

402 related articles for article (PubMed ID: 21365086)

  • 1. Halogen bonding in halocarbon-protein complexes: a structural survey.
    Parisini E; Metrangolo P; Pilati T; Resnati G; Terraneo G
    Chem Soc Rev; 2011 May; 40(5):2267-78. PubMed ID: 21365086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Halogen bonding for rational drug design and new drug discovery.
    Lu Y; Liu Y; Xu Z; Li H; Liu H; Zhu W
    Expert Opin Drug Discov; 2012 May; 7(5):375-83. PubMed ID: 22462734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonbonding interactions of organic halogens in biological systems: implications for drug discovery and biomolecular design.
    Lu Y; Wang Y; Zhu W
    Phys Chem Chem Phys; 2010 May; 12(18):4543-51. PubMed ID: 20428531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Halogen bonding in complexes of proteins and non-natural amino acids.
    Borozan SZ; Stojanović SĐ
    Comput Biol Chem; 2013 Dec; 47():231-9. PubMed ID: 24200696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interplay between halogen bonds and π-π stacking interactions: CSD search and theoretical study.
    Li H; Lu Y; Liu Y; Zhu X; Liu H; Zhu W
    Phys Chem Chem Phys; 2012 Jul; 14(28):9948-55. PubMed ID: 22710562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Energetic effects between halogen bonds and anion-π or lone pair-π interactions: a theoretical study.
    Lu Y; Liu Y; Li H; Zhu X; Liu H; Zhu W
    J Phys Chem A; 2012 Mar; 116(10):2591-7. PubMed ID: 22353010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Halogen bonding--a novel interaction for rational drug design?
    Lu Y; Shi T; Wang Y; Yang H; Yan X; Luo X; Jiang H; Zhu W
    J Med Chem; 2009 May; 52(9):2854-62. PubMed ID: 19358610
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Halogenated ligands and their interactions with amino acids: implications for structure-activity and structure-toxicity relationships.
    Kortagere S; Ekins S; Welsh WJ
    J Mol Graph Model; 2008 Sep; 27(2):170-7. PubMed ID: 18524655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and biological evaluation of novel C5 halogen-functionalized S-DABO as potent HIV-1 non-nucleoside reverse transcriptase inhibitors.
    Qin H; Liu C; Guo Y; Wang R; Zhang J; Ma L; Zhang Z; Wang X; Cui Y; Liu J
    Bioorg Med Chem; 2010 May; 18(9):3231-7. PubMed ID: 20371182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Halogen bonding in halocarbon-protein complexes and computational tools for rational drug design.
    Costa PJ; Nunes R; Vila-Viçosa D
    Expert Opin Drug Discov; 2019 Aug; 14(8):805-820. PubMed ID: 31131651
    [No Abstract]   [Full Text] [Related]  

  • 11. Halogen interactions in protein-ligand complexes: implications of halogen bonding for rational drug design.
    Sirimulla S; Bailey JB; Vegesna R; Narayan M
    J Chem Inf Model; 2013 Nov; 53(11):2781-91. PubMed ID: 24134121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ab initio investigation of the complexes between bromobenzene and several electron donors: some insights into the magnitude and nature of halogen bonding interactions.
    Lu YX; Zou JW; Wang YH; Jiang YJ; Yu QS
    J Phys Chem A; 2007 Oct; 111(42):10781-8. PubMed ID: 17918810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluating the potential of halogen bonding in molecular design: automated scaffold decoration using the new scoring function XBScore.
    Zimmermann MO; Lange A; Boeckler FM
    J Chem Inf Model; 2015 Mar; 55(3):687-99. PubMed ID: 25654403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rational modification of the hierarchy of intermolecular interactions in molecular crystal structures by using tunable halogen bonds.
    Mínguez Espallargas G; Zordan F; Arroyo Marín L; Adams H; Shankland K; van de Streek J; Brammer L
    Chemistry; 2009 Aug; 15(31):7554-68. PubMed ID: 19593826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Halogen bonding in ligand-receptor systems in the framework of classical force fields.
    Rendine S; Pieraccini S; Forni A; Sironi M
    Phys Chem Chem Phys; 2011 Nov; 13(43):19508-16. PubMed ID: 21964576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Principles and applications of halogen bonding in medicinal chemistry and chemical biology.
    Wilcken R; Zimmermann MO; Lange A; Joerger AC; Boeckler FM
    J Med Chem; 2013 Feb; 56(4):1363-88. PubMed ID: 23145854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Halogens in Protein-Ligand Binding Mechanism: A Structural Perspective.
    Shinada NK; de Brevern AG; Schmidtke P
    J Med Chem; 2019 Nov; 62(21):9341-9356. PubMed ID: 31117513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. C-X...H contacts in biomolecular systems: how they contribute to protein-ligand binding affinity.
    Lu Y; Wang Y; Xu Z; Yan X; Luo X; Jiang H; Zhu W
    J Phys Chem B; 2009 Sep; 113(37):12615-21. PubMed ID: 19708644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Halogen bonding in DNA base pairs.
    Parker AJ; Stewart J; Donald KJ; Parish CA
    J Am Chem Soc; 2012 Mar; 134(11):5165-72. PubMed ID: 22364257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Crystal structures of HIV-1 reverse transcriptase with picomolar inhibitors reveal key interactions for drug design.
    Frey KM; Bollini M; Mislak AC; Cisneros JA; Gallardo-Macias R; Jorgensen WL; Anderson KS
    J Am Chem Soc; 2012 Dec; 134(48):19501-3. PubMed ID: 23163887
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.